Accession | PRJCA003895 | ||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Title | Establishment of criteria for molecular differential diagnosis of MPLC and IPM | ||||||||||||||||||||||||||||||||
Relevance | Medical | ||||||||||||||||||||||||||||||||
Data types |
Raw sequence reads
Genome sequencing |
||||||||||||||||||||||||||||||||
Organisms | Homo sapiens | ||||||||||||||||||||||||||||||||
Description | Differential diagnosis of multiple primary lung cancer (MPLC) and intrapulmonary metastasis (IPM) is one difficulty in lung cancer diagnosis, and crucial for establishment of treatment strategies and prognosis prediction. This study aims to establish the criteria for molecular differential diagnosis of synchronous MPLC and IPM by the next-generation sequencing (NGS)method. | ||||||||||||||||||||||||||||||||
Sample scope | Multiisolate | ||||||||||||||||||||||||||||||||
Release date | 2020-11-19 | ||||||||||||||||||||||||||||||||
Grants |
|
||||||||||||||||||||||||||||||||
Submitter | Shifu Chen (chen@haplox.com) | ||||||||||||||||||||||||||||||||
Organization | HaploX Biotechnology Co., Ltd | ||||||||||||||||||||||||||||||||
Submission date | 2020-11-19 |
Resource name | Description |
---|---|
BioSample (158) show | - |